CellaVision (Sweden) Performance
| CEVI Stock | SEK 153.80 1.60 1.03% |
The firm shows a Beta (market volatility) of 0.16, which signifies not very significant fluctuations relative to the market. As returns on the market increase, CellaVision's returns are expected to increase less than the market. However, during the bear market, the loss of holding CellaVision is expected to be smaller as well. At this point, CellaVision AB has a negative expected return of -0.28%. Please make sure to confirm CellaVision's treynor ratio, value at risk, and the relationship between the total risk alpha and maximum drawdown , to decide if CellaVision AB performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days CellaVision AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in February 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
| Begin Period Cash Flow | 102.3 M | |
| Total Cashflows From Investing Activities | -84.3 M |
CellaVision |
CellaVision Relative Risk vs. Return Landscape
If you would invest 18,360 in CellaVision AB on October 29, 2025 and sell it today you would lose (2,980) from holding CellaVision AB or give up 16.23% of portfolio value over 90 days. CellaVision AB is generating negative expected returns and assumes 2.3061% volatility on return distribution over the 90 days horizon. Simply put, 20% of stocks are less volatile than CellaVision, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
CellaVision Target Price Odds to finish over Current Price
The tendency of CellaVision Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 153.80 | 90 days | 153.80 | about 77.71 |
Based on a normal probability distribution, the odds of CellaVision to move above the current price in 90 days from now is about 77.71 (This CellaVision AB probability density function shows the probability of CellaVision Stock to fall within a particular range of prices over 90 days) .
Assuming the 90 days trading horizon CellaVision has a beta of 0.16 suggesting as returns on the market go up, CellaVision average returns are expected to increase less than the benchmark. However, during the bear market, the loss on holding CellaVision AB will be expected to be much smaller as well. Additionally CellaVision AB has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. CellaVision Price Density |
| Price |
Predictive Modules for CellaVision
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CellaVision AB. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CellaVision Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CellaVision is not an exception. The market had few large corrections towards the CellaVision's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CellaVision AB, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CellaVision within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.24 | |
β | Beta against Dow Jones | 0.16 | |
σ | Overall volatility | 11.41 | |
Ir | Information ratio | -0.13 |
CellaVision Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CellaVision for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CellaVision AB can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CellaVision AB generated a negative expected return over the last 90 days | |
| About 38.0% of the company shares are held by company insiders |
CellaVision Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CellaVision Stock often depends not only on the future outlook of the current and potential CellaVision's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CellaVision's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 23.9 M | |
| Cash And Short Term Investments | 130.3 M |
CellaVision Fundamentals Growth
CellaVision Stock prices reflect investors' perceptions of the future prospects and financial health of CellaVision, and CellaVision fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on CellaVision Stock performance.
| Return On Equity | 0.2 | |||
| Return On Asset | 0.12 | |||
| Profit Margin | 0.19 % | |||
| Operating Margin | 0.25 % | |||
| Current Valuation | 6.21 B | |||
| Shares Outstanding | 23.85 M | |||
| Price To Earning | 90.85 X | |||
| Price To Book | 10.18 X | |||
| Price To Sales | 9.60 X | |||
| Revenue | 565.55 M | |||
| EBITDA | 193.6 M | |||
| Cash And Equivalents | 190.2 M | |||
| Cash Per Share | 7.97 X | |||
| Total Debt | 95.84 M | |||
| Debt To Equity | 9.10 % | |||
| Book Value Per Share | 26.90 X | |||
| Cash Flow From Operations | 159.72 M | |||
| Earnings Per Share | 5.27 X | |||
| Total Asset | 825.21 M | |||
| Current Asset | 195 M | |||
| Current Liabilities | 40 M | |||
About CellaVision Performance
Assessing CellaVision's fundamental ratios provides investors with valuable insights into CellaVision's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the CellaVision is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
CellaVision AB develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden and internationally. CellaVision AB was founded in 1994 and is headquartered in Lund, Sweden. CellaVision operates under High Precision And Instrumentation Products classification in Sweden and is traded on Stockholm Stock Exchange. It employs 129 people.Things to note about CellaVision AB performance evaluation
Checking the ongoing alerts about CellaVision for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for CellaVision AB help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| CellaVision AB generated a negative expected return over the last 90 days | |
| About 38.0% of the company shares are held by company insiders |
- Analyzing CellaVision's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether CellaVision's stock is overvalued or undervalued compared to its peers.
- Examining CellaVision's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating CellaVision's management team can have a significant impact on its success or failure. Reviewing the track record and experience of CellaVision's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of CellaVision's stock. These opinions can provide insight into CellaVision's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for CellaVision Stock Analysis
When running CellaVision's price analysis, check to measure CellaVision's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CellaVision is operating at the current time. Most of CellaVision's value examination focuses on studying past and present price action to predict the probability of CellaVision's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CellaVision's price. Additionally, you may evaluate how the addition of CellaVision to your portfolios can decrease your overall portfolio volatility.